Lorazepam

Tavor, Control e altri

Bibliografia - Quali fonti bibliografiche per Lorazepam?

1. Ashton H., Textbook of Adverse Drug Reactions, 3rd Ed., 1985, Oxford University Press.


2. Brook S. et al., J. Clin. Psychiatry, 2000, 61, 933.


3. Carrasco M.C., Phytother. Res., 2009, DOI, 10.1002/ptr.2847.


4. Cummings A.J., Whitelaw A.G.L., Br. J. Clin.Pharmacol., 1981, 12, 511.


5. Drug Ther. Bull., 1980, 18, 97.


6. Einarson T.R., Lancet, 1980, 1, 151.


7. Feltner D.E. et al., J. Clin. Psychopharmacol., 2003, 23, 240.


8. Foster S. et al., Int. Clin. Psychopharmacol., 1997, 12, 175.


9. Garcia Pena B.M., krauss B., DoctorPediaria, 2002, n 1, gennaio


10. Herman R.J. et al., Clin. Pharmacol. Ther., 1989, 46, 18.


11. Klimke A., Klieser E., Am. J. Psychiatry, 1994, 151, 780.


12. Langer S.Z. et al., Imidazopyridines in Sleep Disorders: a novel experimental and therapeutic approach (Sauvanet J.P. et al., Ed.), 1988, Raven Press, N.Y., 11.


13. Lee S.A. et al., Seizure, 2002, 11, 124.


14. Meatherall R.C. et al., J. Ann. Toxicol., 1983, 7, 168.


15. Meehan K. et al., J. Clin. Psychopharmacol., 2001, 21, 389.


16. Pande A.C. et al., Am. J. Psychiatry, 2003, 160, 533.


17. Souchet E. et al., Pharmacoepidemiol. Drug Safety, 2005, 14, 11.


18. Summerfield R.J., Nielsen M.S., Br. J. Anaesth., 1985, 57, 1042.


19. U.S. Food and Drug Administration, 2003, Code of Federal Regulations, Title 21, Volume 4. Washington, DC: U.S. Government Printing Office. pag. 21.


20. Wright P. et al., Am. J. Psychiatry, 2001, 158, 1149.


21. Yildiz A. et al., Emerg. Med. J., 2003, 20, 339.

Link
www.healthsystem.virginia.edu
consultato online in data 16 ottobre 2014 https://healthsystem.virginia.edu/intranet/pi/ghidelines/clinguide/drugchart_sedped.pdf